CH404 | Heir
Added 2025-09-02 16:34:12 +0000 UTCThe next day.
I told Vice Chairman Han about the negotiations with Vice Chairman Oh Yong-jae.
He scratched his head, looking like he had a lot to say.
âSomething doesnât sit right with you, does it?â
âTo be honest, I just donât understand. I know this is at Chairman Oh Hee-gunâs request, but I donât see why we have to go this far. Samsung Group is the only real rival Taewoo Group has in Korea. Wouldnât it be better for us to simply leave them alone? That would help Taewoo in many ways.â
Vice Chairman Han had truly become a man of Taewoo.
His way of thinking revolved entirely around what benefited Taewoo Group.
âIf we only look at the short term, then yes. If Vice Chairman Oh Yong-jae goes to prison and Samsung Group takes public heat for accounting fraud, we might even gain from it.â
âThatâs exactly what I was thinking. Of course, Samsung Group wouldnât collapse from something like that, but theyâd definitely stumble.â
âTaewoo has its limits. Even if weâre called a multinational company, at the end of the day weâre still based in Korea. If we want to grow even higher, weâll need the cooperation of other Korean conglomerates too.â
Samsung Group was no longer a rival.
Taewoo Group had already moved beyond Korea and was running toward the top of the world. There was no need to hold Samsung back anymore.
âDo you think Samsung sees it that way? Even if we help them now, theyâll always be looking for an opening to overtake us.â
âLet them try. All I want from them is to shield us from the government and the press.â
âYou expect Samsung to play the role of a dam?â
âWhenever a new administration comes in, they look for a scapegoat. As long as Samsung Group stays strong, Taewoo wonât be the target.â
âStill, this feels like too much. Especially granting them joint production rights for insulin and the flu treatment. Thatâs far too generous.â
Samsungâs very existence was already a huge benefit to us.
There was no need to go so far as to share insulin and flu production rights.
And yet, I had decided to do exactly that. Not only because we had a new drug to serve as our cash cow, but also for another reason.
âFor Koreaâs bioindustry to advance, Samsung Bio has to grow as well. A time will come when enormous quantities of medicine will need to be produced here in Korea.â
âYou mean the diet drug?â
âNot just that. If another massive epidemic like the swine flu breaks out, the entire Korean bioindustry will need to grow together to handle it.â
It was said with the coronavirus in mind.
At the moment, no one could have imagined that the coronavirus would ever spread.
But Centurion and the Taewoo AI Center were already researching pandemics like it.
The moment the coronavirus broke out, Centurion would be the fastest among all pharmaceutical companies to develop a treatment.
That would mean producing an enormous quantity of medicine, and Centurionâs factories alone could never keep up with demand.
âAre you saying Samsung Bioâs growth will help Centurion grow as well?â
âItâll help a great deal. To be precise, for us to increase our revenue, Samsung Bio has to get bigger.â
The most profitable business in the end was royalties.
With new drugs, the royalty business was massive.
The larger Samsung Bio became, the more drugs it could produce, and the more royalties we could collect.
âWouldnât it be better just to expand Centurion instead? Why bother sharing with Samsung Bio?â
âIf demand drops, the factories would stop running. For risk management, we canât handle all production ourselves.â
âSo when demand is low, Centurion will produce alone, and when demand is high, Samsung Bio will take on some of the orders?â
âExactly. Itâs excellent for risk management, donât you think?â
I was a Taewoo man too.
Aside from my grandfather, no one was more Taewoo to the core than I was.
Of course, all of my plans put Taewoo first. The joint growth with Samsung Group was necessary only because it benefited Taewooâs development.
âIf things go as you say, Chairman, then itâll indeed be a huge help for risk management.â
âAnd it will go that way, so donât worry. More importantly, how are things progressing in China? I heard cheers all over when we moved into the Financial Tower. The situation must be looking good.â
âThe downturn continues. The market has already fallen more than 15%.â
A drop of over 15% in less than a month.
For a short seller, such a falling market was a rare opportunity.
And the decline wasnât over yet.
âThe Chinese stock market will fall to the 2,800 level. Keep short-selling.â
âLast month, the Chinese market was at 5,100. Are you saying it will drop by more than 40%? Iâve heard the government is preparing various measures to stop the decline.â
The Chinese government was indeed making every effort to prevent the fall.
But all of it was in vain. None of their efforts could stop the market that was plunging off a cliff.
âThe downturn will last until January next year. Plan your exit for around mid-January.â
âIf the Chinese market really drops by more than 40%, ⊠we could earn even more than we did during the oil war.â
âExactly why we spend so much on lobbying the Chinese elite. Do you think I hand them money for nothing?â
âLooking back now, it doesnât feel like a waste at all. If anything, it feels like we got off cheap.â
It wasnât just the market itself that was falling.
A declining stock market was proof that companies were struggling.
Every day, dozens of Chinese companies were going bankrupt.
âAnd once stock prices hit bottom, weâll buy stakes in a few solid companies.â
âAre you planning to acquire stakes in IT firms?â
âIn a variety of companies. IT, of course, but also liquor companies.â
âWhen you say liquor companies, do you mean Maotai? It has nothing to do with Taewoo Group.â
But liquor wasnât completely unrelated to Taewoo.
Taewoo Trading already held the rights to sell a wide range of drinks, from cola to coffee. Adding liquor on top of that wouldnât be strange at all.
âAcquire a stake in Maotai under Taewoo Tradingâs name. Itâll be a big help for the company.â
âMaotai may be the most famous liquor company in China, but I didnât think it was important enough to catch your attention, Chairman.â
âThatâs only true for now. In just a few years, its market cap will surpass Coca-Cola and Pepsi.â
Vice Chairman Han could hardly believe his ears.
It was understandable. At that time, Maotaiâs stock price was only around 250 yuan.
By January, it would plunge even further, down to about 195 yuan.
And yet here was the claim that such a company would one day surpass Coca-Cola in market capitalization. Who could believe that?
But Maotai wouldnât just surpass Coca-Cola.
It would grow into a giant liquor company so massive that it would even overtake Samsung Groupâs market cap.
In the span of just five years, it had the potential to increase nearly tenfold.
âYou rate Maotaiâs potential that highly?â
âEven if only half of my prediction comes true, weâll still make at least three times our money. Do you still object?â
âNo, sir! If we can triple our money, we must buy it without question.â
âStart securing shares gradually at the end of this year. Then, once January comes, move aggressively to acquire more.â
âThe short sellers are dumping a massive volume of liquor stocks into the market. It shouldnât be difficult to acquire a position.â
The profits could come from Maotai.
But aside from high returns, Taewoo Group also needed to acquire companies that would support its strategic growth, even if the profit margin wasnât as large.
âIf you can, acquire a Chinese shipping company as well. Of course, weâll first crush them with short selling and then buy them cheaply afterward.â
âIâll put together a plan so we can acquire a shipping company of decent size.â
The Chinese cultural ban and the looming US-China power struggle were not far away.
Before that, we had to extract as much profit from China as possible to minimize the damage.
Not just minimize it, but position ourselves to lead. That meant when the opportunity appeared, we had to seize it with everything we had.
***
A few days later.
I went to visit Centurion.
CEO Seo Jeong-jun and Dr. Kim Jang-woo were waiting for me, both wearing slightly gloomy expressions.
âYou look rather down. I take it the contract with Samsung Bio has weighed heavily on you.â
âI knew the contract was going to happen, but now that weâre actually carrying it out, it doesnât sit well with me.â
Centurionâs CEO was Seo Jeong-jun.
That was why, before negotiating with Samsung Groupâs Vice Chairman Oh Yong-jae, I had already spoken with Seo over the phone.
I had told him there was a possibility we might collaborate with Samsung Bio.
Even then, he hadnât reacted positively, but he couldnât oppose my decision outright, so he had let it pass.
âLet me make one thing clear. I made that decision for the sake of Centurionâs growth. If Centurion suffers even the slightest loss, I will personally compensate with my own assets.â
âNo, sir, that wasnât my intention. Itâs just⊠handing over the manufacturing technology we worked so hard to master to Samsung Bio doesnât feel good.â
It was an understandable feeling.
They had bowed their heads to learn the know-how, endured countless trials and errors, and finally mastered the manufacturing process.
Now they were expected to hand over not just the technology but also Plant 1. How could that sit comfortably with anyone?
âCenturion canât keep producing only insulin and swine flu treatments forever. The day will soon come when even our factories wonât be enough just to produce the new drug Centurion is developing.â
âYou mean the diabetes treatment currently under development?â
âYes. A diabetes treatment and at the same time a miracle diet drug. Itâs a new medicine that will generate hundreds of times more revenue than insulin or the swine flu treatment. A true cash cow.â
CEO Seo scratched his head.
From his reaction, he clearly didnât expect the new drug in development to bring in anywhere near that level of revenue.
âThe development is proceeding without any setbacks. Dr. Kim Jang-woo is leading the project.â
âTo be honest, itâs hardly even development. Novo Nordisk already completed over 99% of it. Weâre just making slight modifications.â
Dr. Kim Jang-woo spoke with an embarrassed look.
He felt ashamed to say that he was developing a new drug when, in truth, someone else had already done almost all the work.
âHow soon do you think the new drug can be completed?â
âIf things go quickly, it could be ready by the second half of this year. Honestly, we could release it right now and it would be fine. There are no fatal side effects at all. In fact, thereâs hardly anything I need to adjust.â
âThen, CEO Seo, please take the lead in moving the FDA approval process forward as quickly as possible. Taewoo Group will help to expedite things on our side.â
There seemed to be no issues with the new drugâs development.
Which meant it was time to focus on the next one.
A few years from now, a coronavirus treatment would emerge, and I was determined to make sure Centurion monopolized it.